
    
      ASV remain the optimal treatment for CSA in Heart Failure patients with preserved left
      ventricular ejection fraction (LVEF).

      Yet, the adaptation to the ventilation is extremely challenging and the resulting
      difficulties encountered to sleep induction might be a reason for dropping out.

      Zopiclone is indicated for the short-term treatment of insomnia where sleep initiation or
      sleep maintenance are prominent symptoms. In this study, Zopiclone, as sedative and hypnotic
      agent, is used during the ASV initiation period.
    
  